
|Articles|May 9, 2008
Bevacizumab improves success rate of augmented trabeculectomy for neovascular glaucoma in young diabetic patients
The addition of bevacizumab (Avastin) to trabeculectomy improves the success rate of IOP control, particularly in young diabetic patients with neovascular glaucoma (NVG), according to a study published online, ahead of print, by Eye.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA requires NAION warning across the GLP-1 receptor agonist class
2
VERONA: Katherine Talcott, MD, on early gains with a TKI insert in DME
3
Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia
4
The One Thing: GA’s last frontier, the toll of ongoing care, back to glucose basics | Episode 6
5













